Deutsche Märkte öffnen in 25 Minuten

Baudax Bio, Inc. (BXRX)

NasdaqCM - NasdaqCM Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
1,2900-0,1700 (-11,64%)
Börsenschluss: 4:00PM EDT
Melden Sie sich an, um eine Nachricht zu posten.
  • w
    wererabbit
    $BXRX conversation
    Aquaman2 months ago
    $BXRX
    About 3 month to Q3 results. The price will tank. Nothing to keep it up. -----Well Aquaman, now you pump it when Q3 is still a month away? Hmm, didn't sell those $5 shares like you shoulda
  • p
    pro_buystocks_$12
    $BXRX conversation
    How to be a MILLIONAIRE? BUY $BXRX
  • c
    changed_mind_longnow
    $BXRX conversation
    Most undervalued/oversold stock $BXRX, bye bye August.
  • A
    Amy B
    $BXRX conversation
    Here's my "best case scenario:" $BXRX rockets up tomorrow on high volume (it wouldn't take much) & suddenly it's on everyone's radar; spikes to $8-10, gets shorted & eventually settles between $4&5
  • T
    Tell us all now
    $BXRX conversation
    No big deal today's price is Market related. Best time to Buy when $BXRX is down!!!
  • E
    Explorer
    $AIM conversation
    Thumbs up if you hate the CEO's of $AIM, $BIOC, $FCEL, $BXRX / $REPH, $OMER, and $NNDM.
  • S
    So
    $BXRX conversation
    hey shorts don't worry be happy just another GreeN day for $BXRX
  • D
    Donald
    Baudax Bio, Inc.
    No news here. Coming quarters project a 500% to 1000% increase in revenue. Today TRVN ran on approval. $BXRX IS Already at Market. This will hit $4.20 and then breakout soon enough.
  • L
    Leo
    I thought I was supposed to get $BXRX today but still not in my brokerage account. Is it today or tomorrow?
  • T
    Tell us all now
    $BXRX conversation
    We had a few down days with low volume NO big deal. $BXRX Stock in a BUY right now!!!
  • S
    Stallions
    BlackRock, Inc. just provided an update on share ownership of Baudax Bio, Inc. conferencecalltranscripts.o... $BXRX
  • S
    So
    $BXRX conversation
    $BXRX will close Very Strong watch!!
  • B
    Big
    $AGRX conversation
    I'm back in $AGRX approval looks positive for Twirla on Feb 16th (most likely to be announced on February 14th). I've taken a position in $BXRX pending approval on Feb. 20th for meloxicam an opioid-free pain medicine--the FDA should definitely be approving something like this compared to all the opiates they have approved to the detriment of many who have gotten hooked.
  • c
    changed_mind_longnow
    $BXRX conversation
    This is a great time to buy $BXRX, see you at $5.00 SO_ON
  • c
    changed_mind_longnow
    $BXRX conversation
    Thank GOD finally, I bought so more $BXRX under $4.00
  • r
    rachid
    $BXRX conversation
    For comparison: $PCRX which bread-winner is EXPAREL, a non-opioid medication administered at the time of surgery to control pain while reducing opioid requirements, has revenues of about $400M. It trades at 4 times revenue.

    If as analysts predicts, $BXRX reaches peak revenue of $350M, if you apply an even lower multiple, say 2.5, you'd get to a $875M market cap. If fully diluted we end up with 25M shares --> you'd get at a share price of: 35$ !!!!!!

    If Peak sales are overestimated and we just get half of it, PPS should still be, if you follow $PCRX metric at $17!!!!

    THAT IS A 630% GAIN FROM TODAY'S PRICE!!!!!!!!!!!!!!!

    And people still sell this stock! smh.
  • S
    So
    $BXRX conversation
    You can't keep a good stock down for long, $BXRX soon to explode violently over $5.00
  • E
    Eric
    $BXRX conversation
    $BXRX they have a 25 million offering they filed last December, at the market offering
  • p
    pro_buystocks_$12
    $BXRX conversation
    Any New Investors, anybody bought some $BXRX shares today at these bargain prices? Lucky You$
  • B
    Big
    $TSLA conversation
    Congrats to any options traders in $TSLA. You really can't complaint about 3000% increase--like once in a lifetime bet, right? I'm in $AGRX with FDA approval for Twirla (birth control patch worn 1 x per week) pending Feb. 14 and $BXRX with FDA approval pending Feb. 20 for major pain-reliever (post-surgery, etc.) without any opiates/opioids.